-
New Company Acquires Off-the-Shelf T-Cell Cancer Therapies
A new enterprise is formed to develop treatments for cancer using donated T-cells from the immune system, rather than the patient’s own T-cells, engineered to attack cancer cells.
-
Cough Suppressant Produced from Engineered Yeast Cells
A bioengineering group created a process for producing a cough suppressant in the lab, usually derived from opium poppies, but instead from genetically modified brewer’s yeast.
-
Nanotech Pain Drug Formulations Developed
A pharmaceutical researcher developed treatments for chronic pain, formulated as nanoscale droplets, that in tests with lab animals target the source of pain directly and use much smaller doses than current pain drugs.
-
Antibodies Licensed for Multi-Target Immunotherapies
MedImmune, the biologics subsidiary of drug maker AstraZeneca, is licensing antibodies from a biotechnology company for treatments that simultaneously address two or more cancer targets.
-
Complications Can Result from Plastic Surgery Tourism
Surgeons at a Boston hospital report a continuing flow of cases where people go overseas for plastic surgery, only to encounter complications needing repair, including drug-resistant bacterial infections, after they return.
-
RNA Treatment Tested for West Nile Virus
A therapy for West Nile Virus made with interfering RNA molecules is shown in lab mice to reduce viral loads, including in the brain where the disease can do serious damage.
-
Time To Replace Your Business Equipment? Let’s Find Out
What are the signs that you do need to upgrade your tech and how should you handle it when this day comes?
-
Team Performance Explored in Multi-Sensory Work Sites
A research project is underway that examines the ways teams of workers adapt and perform in new industrial environments demanding attention to visual information as well as cues from sound and touch.
-
Drug Shown Able to Kill Malaria-Carrier Mosquitoes
A clinical trial in Kenya shows blood from people who take a current anti-parasite drug can kill mosquitoes carrying malaria, offering a potential new strategy for controlling this disease.
-
FDA Authorizes Interoperable Glucose Monitoring System
The Food and Drug Administration authorized a device that electronically monitors blood glucose levels in people with diabetes, but is also designed to exchange data with other compatible electronic systems.